🟢 GT Biopharma is trading 5% up in after-hours trading

GT Biopharma is trading 5.03% up at $6.47 in after-hours trading; no specific October 5 catalyst was identified.

• The stock closed the regular session at $6.16, up 0.98% on October 5.
• The latest listed press release was September 15, about a potential new indication for GTB-5550; available evidence does not establish it as the cause of this move.
• The broad market was positive, but evidence does not confirm it drove the move.